Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance

  title={Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance},
  author={Jennifer E. Layden and Jonathan Anthony Michaels and Sarah L Bermingham and Bernard Higgins},
  journal={BMJ : British Medical Journal},
Lower limb peripheral arterial disease (referred to as peripheral arterial disease in this summary) is common, affecting 3% to 7% of people in the general population and 20% of people over the age of 75.1 It is associated with an increased risk of cardiovascular morbidity and mortality and severely limits people’s functional capacity and quality of life. Peripheral arterial disease is often asymptomatic, but when it is symptomatic the most common presentation is intermittent claudication (pain… 

Lower extremity peripheral artery disease: a basic approach.

Early administration of basic pharmacotherapy and lifestyle changes to reduce cardiovascular events, minimise claudication symptoms and enable optimal revascularisation to prevent loss of limb function are recommended.

Screening for peripheral artery disease.

An overview of the current management of PAD is provided, the constellation of low clinical detection rate, significant disability, and dramatically increased risk of adverse cardiovascular events, together provide the rationale behind screening for PAD.

Lower extremity amputation in peripheral artery disease: improving patient outcomes

Methods to reduce the significance of LEA and methods to reduce its occurrence include improved recognition of the risk factors for LEA by clinicians and patients, strong advocacy for noninvasive and/or invasive imaging prior to LEA, improved endovascular revascularization techniques, and novel therapies.

Non-Invasive Management of Peripheral Arterial Disease.

There is a building body of literature to support the use of electrical stimulators in PAD, but this is low level to date and devices may be of special benefit to those with limited exercise capacity, and in non-reconstructable critical limb ischaemia.

Factors influencing quality of life after lower extremity amputation for peripheral arterial occlusive disease

Quality of Life was influenced by several factors, primarily participation, which was improved if limb-fitted, and level of mobility was poor for all levels of LEA and there was a positive association between mobility (PLUS-M) and QoL.

Invasive screening for lower extremity peripheral artery disease: Killing two birds with one stone?

Routine screening for lower extremity peripheral disease patients undergoing coronary angiography may be useful in selected patients, and the diagnostic utility of these predictors and their combinations were determined.

Intermittent claudication - studies on clinical evaluation strategies and invasive treatment efficacy

It is established that a primary strategy of revascularization, when added to best medical treatment and structured non-supervised exercise training, improves quality of life and important aspects of walking capacity in patients with intermittent claudication.

Main Findings on Therapeutic Management of Lower Extremity ArteryDisease

The aim of this review is to summarize the key findings and the updates in the field of diagnostic methods and non- surgical therapeutic approaches for this disease.

Economic model to examine the cost-effectiveness of FlowOx home therapy compared to standard care in patients with peripheral artery disease

FlowOx™ therapy delivered as a single annual dose may be a cost-effective treatment for peripheral artery disease and improve health outcomes and reduced treatment costs in this modelled cohort.



Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.

Subjects with asymptomatic peripheral arterial disease appear to have the same increased risk of cardiovascular events and death found in claudicants.

Low recognition of post-traumatic stress disorder in primary care

The Improving Access to Psychological Therapies (IAPT) programme will make the NICE recommended treatments more widely available and will allow self-referral by adults with PTSD to trauma-focused psychological therapy.

Epidemiology of anxiety disorders.

The overall prevalence of anxiety disorders is shown to be quite high, but with considerable variation from the most prevalent (specific phobias) to the least prevalent (agoraphobia without a history of panic disorder) disorders.

A guide to guidelines for the treatment of PTSD and related conditions.

The aim of this article is to examine the various guidelines and to compare and contrast their methodologies and recommendations to aid clinicians in making decisions about their use.

Vascular Society of Great Britain and Ireland

The following abstracts are from papers presented at the prize sessions of the 42nd annual scientific meeting of the Vascular Society of Great Britain and Ireland, held in Manchester on 28th–30th

Post-traumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-being

R rape and sexual molestation were the traumatic events most likely to be associated with PTSD, and a high level of Axis 1 co-morbidity was found among those persons with PTSD.

The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders.

Roughly 1 in 10 children have at least one DSM-IV disorder, involving a level of distress or social impairment likely to warrant treatment, and comorbidity reported between some childhood diagnoses may be due to the association of both disorders with a third.

Posttraumatic stress disorder in the National Comorbidity Survey.

Progress in estimating age-at-onset distributions, cohort effects, and the conditional probabilities of PTSD from different types of trauma will require future epidemiologic studies to assess PTSD for all lifetime traumas rather than for only a small number of retrospectively reported "most serious" traumAs.